Author

Basia Adamiak

Observed name: B ADAMIAK

Institution: Weill Cornell Medicine

Observed institutions: Citigroup, Cornell University, Weill Cornell Medicine, Baxter (United States)

OpenAlex ID: A5078762489

18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease

2008 · Norman R. Relkin, Paul Szabo, et al. · Neurobiology of Aging · 305

Longitudinal analysis of novel A lzheimer's disease proteomic cerebrospinal fluid biomarkers during intravenous immunoglobulin therapy

2012 · Gilda Shayan, Basia Adamiak, et al. · Electrophoresis · 12

O2–05–05: IVIg contains antibodies against oligomers and fibrils of beta amyloid

2007 · Norman R. Relkin, Diana M. Mujalli, et al. · Alzheimer s & Dementia · 11

O3–05–04: Intravenous immunoglobulin (IVIg) maintains cognition over 18 months in patients with Alzheimer's disease (AD)

2006 · Basia Adamiak, Carmen Monthe, et al. · Alzheimer s & Dementia · 5

Longitudinal effects of intravenous immunoglobulin on A lzheimer's cerebrospinal fluid proteome

2014 · Gilda Shayan, Basia Adamiak, et al. · Electrophoresis · 3

P4–251: Decreased plasma beta amyloid levels in Alzheimer patients treated chronically with Intravenous immunoglobulin (IVIG)

2006 · Norman R. Relkin, Linda Younkin, et al. · Alzheimer s & Dementia · 3

O3‐13‐05: The Gammaglobulin Alzheimer Partnership Study (GAP): Design, screening, enrollment and futility analysis results

2012 · Norman Relkin, Devon Gessert, et al. · Alzheimer s & Dementia · 2

[11C]PIB imaging in primary progressive aphasia and Alzheimer disease

2007 · Charles Kreisl, Norman Relkin, et al. · Journal of Nuclear Medicine · 1

P4‐225: A confirmatory phase 3 randomized, double‐blind, placebo‐controlled study of the safety and effectiveness of immune globulin intravenous (Human), 10% solution (GAMMAGARD LIQUID/KIOVIG) for the treatment of mild to moderate Alzheimer's disease

2011 · Deborah A. Lee, Leock Y Ngo, et al. · Alzheimer s & Dementia

Infusion of Intravenous Immunoglobulin (IVIg) Containing anti-Abeta Antibodies is Associated with a Decrease of Abeta in Cerebrospinal Fluid (CSF) and Increase of Abeta in Blood from 8 Patients with Mild Alzheimer's Disease (AD)

2008 · M WEKSLER, P SZABO, et al. · Journal of Allergy and Clinical Immunology

P2–166: Proteomic analysis of antemortem cerebrospinal fluid for Alzheimer's disease biomarkers and in the assessment of IVIg immunotherapy

2006 · Kelvin Lee, Erin Finehout, et al. · Alzheimer s & Dementia

[O2‐01‐04]: Drug‐ranging study of intravenous immunoglobulin in patients with Alzheimer's disease

2005 · Marc Weksler, Paul Szabo, et al. · Alzheimer s & Dementia

Works count: 12

Citation count: 342

H-index: 4

I10-index: 3